QUARTERLY RESULTS
AstraZeneca Pharma India Ltd.
BSE
Jun 19, 04:01
9422.95
-311.70 ( -3.20%)
Volume
4381
Prev. Close
9734.65
Open Price
9599.85
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 19, 03:59
9410.50
-324.00 ( -3.33%)
Volume
40260
Prev. Close
9734.50
Open Price
9680.50
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
9410.50 (55)
You can view the
Quarterly Results
for the last 5 years.
|
ISIN No
|
INE203A01020
|
Market Cap. ( ₹ in Cr. )
|
23526.25
|
P/BV
|
34.63
|
Book Value ( ₹ )
|
271.74
|
|
BSE Code
|
506820
|
52 Week High/Low ( ₹ )
|
10691/6070
|
FV/ML
|
2/1
|
P/E(X)
|
203.27
|
|
NSE Code
|
ASTRAZENEQ
|
Book Closure
|
05/07/2024
|
EPS ( ₹ )
|
46.30
|
Div Yield (%)
|
0.34
|
(₹ in Crs.)
| Net Sales/Income from operations | 480.48 | 440.29 | 408.00 | 387.52 | 383.20 |
| Total Income From Operations | 480.48 | 440.29 | 408.00 | 387.52 | 383.20 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 94.25 | 69.88 | 77.15 | 45.85 | 33.62 |
| Purchase of Traded Goods | 287.86 | 228.76 | 251.87 | 240.33 | 74.98 |
| Increase/Decrease in Stocks | -122.50 | -51.61 | -103.09 | -55.74 | 104.95 |
| Employees Cost | 66.07 | 62.37 | 68.04 | 60.96 | 57.98 |
| Depreciation | 17.69 | 9.07 | 9.32 | 3.91 | 3.76 |
| Admin. And Selling Expenses | 22.02 | 22.74 | 0.00 | 0.00 | 0.00 |
| Provisions And Contingencies | 0.00 | -0.17 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 46.41 | 31.33 | 61.48 | 58.04 | 62.28 |
| Total Expenses | 411.80 | 372.37 | 364.77 | 353.35 | 337.57 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 68.68 | 67.92 | 43.22 | 34.17 | 45.62 |
| Other Income | 16.15 | 7.98 | 8.15 | 8.35 | 8.66 |
| P/L Before Interest, Excpt. Items & Tax | 84.83 | 75.90 | 51.38 | 42.52 | 54.29 |
| Interest | 0.68 | 0.33 | 0.34 | 0.11 | -0.07 |
| P/L Before Exceptional Items & Tax | 84.15 | 75.57 | 51.03 | 42.41 | 54.35 |
| Exceptional Items | -5.68 | -33.55 | 0.00 | -57.56 | 0.00 |
| P/L Before Tax | 78.47 | 42.02 | 51.03 | -15.16 | 54.35 |
| Tax | 20.22 | 11.17 | 12.60 | -3.37 | 14.88 |
| P/L After Tax from Ordinary Activities | 58.25 | 30.85 | 38.43 | -11.79 | 39.48 |
| Net Profit/Loss For the Period | 58.25 | 30.85 | 38.43 | -11.79 | 39.48 |
| | | | | | |
| Equity Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 23.30 | 12.34 | 15.37 | -4.72 | 15.79 |
| Diluted EPS (Rs.) | 23.30 | 12.34 | 15.37 | -4.72 | 15.79 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 23.30 | 12.34 | 15.37 | -4.72 | 15.79 |
| Diluted EPS (Rs.) | 23.30 | 12.34 | 15.37 | -4.72 | 15.79 |
| | | | | | |
| PBITOE Margin (%) | 14.29 | 15.42 | 10.59 | 8.81 | 11.90 |
| PBTE Margin (%) | 17.51 | 17.16 | 12.50 | 10.94 | 14.18 |
| PBT Margin (%) | 16.33 | 9.54 | 12.50 | -3.91 | 14.18 |
| PAT Margin (%) | 12.12 | 7.00 | 9.41 | -3.04 | 10.30 |